Editorial
Diagnosis of Irritable Bowel Syndrome: What Are We Missing?
Abstract
Over the past several decades, irritable bowel syndrome (IBS) has earned its place as a diagnosis among primary care providers and gastroenterologists due to its increasingly high prevalence, between 3–20%, and its debilitating symptoms. Aside from the health concerns to the patient, the societal and economic impacts of IBS are substantial resulting in exorbitant healthcare expenditures.1This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.